BU-NOT-SET

CONTACT US
Explore Recipharm's Full Service Offering
  • Corporate
Recipharm_packaging
Brochure
Successful drug development
  • Drug product
Eyes
Insight
How CDMOs can help reduce the risk of counterfeit medicines entering the supply chain
  • Manufacturing
Eyes
Insight
Tackling complexity in scale-up
  • Drug product
Lab equipment
Insight
Navigating COVID-19 – the role of CDMOs
  • Industry trends
Eyes
Insight
Best pharmaceutical dosage forms
  • Drug product
Production line
Insight
Taking an innovative approach to analytical chemistry
  • Analytical chemistry
Eyes
Insight
Recipharm and Oncopeptides collaborate in the development of Melflufen for the treatment of multiple myeloma
  • Analytical chemistry
Eyes
Insight
Excipients for orally disintegrating products
  • Drug product
Eyes
Insight
Insight
  • Drug substance
Relocating API supply to avoid over-reliance
Case study
  • Drug product
Modified release fixed dose combination product with two poorly soluble drug substances
Insight
  • Drug product
Patient centricity during drug development and commercialisation
Insight
  • Drug product
10 considerations to kick-start your drug development journey
Insight
  • Drug product
Guidance for start-ups on drug development
White paper
  • Drug product
  • Drug substance
Drug development for start-ups
Insight
  • Sustainability
Optimising environmental sustainability
Insight
  • Industry trends
Adapting to deal with the COVID-19 pandemic
Insight
  • Sustainability
On Drug Delivery – Sustainability Q&A